Search results for " survey"

Article CMOs Continue to Improve Overall Biomanufacturing Performance
Results from BioPlan Associates’ 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production (1) offer some clues as to what CMOs are doing to remain competitive. CMOs…

Article Biomanufacturing Outsourcing Globalization Continues
…d States and Europe, according to preliminary data from BioPlan Associates’ 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production (1). As part of the survey, bi…

Article Relationship Building at Top of Mind for Clients
As results from BioPlan Associates’ 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production (1) show, however, it’s no longer enough for CMOs to lay claim to technolog…

Article Outsourcing Trends in Biopharmaceutical Manufacturing
According to BioPlan Associates’ 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production (1), outsourcing and off-shoring have migrated into much more high-value areas…

Article 2014 Manufacturing Trends and Outlook
In a recent survey of current trends and practices in biopharmaceutical manufacturing, BioPharm International readers revealed a preference for disposable systems, identified challenges for different …

Privacy Policy
In market research studies, we may track what computers respond to a survey. This information enables us to better provide Services and content and to respond to our users' needs. It also is used to h…

Article Managing Biomanufacturing Capacity Expectations
According to a new survey by BioPlan Associates, more than half of respondents (60%) expect facility constraints to create biopharmaceutical production capacity constraints by 2021 (1). BioPlan found …

Article Changing the Culture of Cell Culture: Applying Best Practices and Authentication to Ensure Scientific Reproducibility
One widely cited survey reported that only one-third of laboratories tested their cell lines for identity (24). A Nature Cell Biology editorial reported that only 19% of papers using cell lines publis…

Article CMOs Concerned With Cost of Single-Use Equipment
When the more than 200 survey respondents were asked to identify the most important reason for not increasing use of disposable technologies, a new ranking of obstacles was found, as differences betwe…

Article Early Communication with Regulators is Essential for SMEs
Understanding the route to drug approval “From a survey we did in 2011, we found that a lot of SMEs lack personnel with experience of bringing products through the regulatory system. As a result, …

Previous PageNext Page